04 August 2025
04 August 2025
Analysts call the revenue drop driven by dipping Covid vaccine sales ‘unsurprising’.
Issues were picked up during an FDA inspection of Novo Nordisk-owned Catalent’s mammoth filling plant.
Europe’s cannabis pharmaceutical sector is shifting as scientific rigour, regulatory clarity and cautious capital define its next chapter.
The investigational RNA interference therapeutic candidate reduces polipoprotein C-III production.
Atombeat expedites drug discovery using its Hermite software and RiDYMO platform.
Eli Lilly’s trial evaluating Mounjaro in reducing cardiovascular risk met its endpoint, though missed analyst expectations.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
